These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 22400902

  • 21. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q, Wang C, Lu Z, Guo L, Ge Q.
    Clin Chim Acta; 2012 Jul 11; 413(13-14):1058-65. PubMed ID: 22387599
    [Abstract] [Full Text] [Related]

  • 22. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T, Hirschfeld M, Rücker G, Jaeger M, Boas J, Iborra S, Mayer S, Gitsch G, Stickeler E.
    BMC Cancer; 2015 Mar 28; 15():193. PubMed ID: 25886191
    [Abstract] [Full Text] [Related]

  • 23. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
    Eissa S, Matboli M, Shehata HH.
    Transl Res; 2015 Mar 28; 165(3):417-27. PubMed ID: 25445205
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.
    Breast Cancer Res Treat; 2015 Nov 28; 154(2):423-34. PubMed ID: 26476723
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients.
    Bahmanpour Z, Sheervalilou R, Choupani J, Shekari Khaniani M, Montazeri V, Mansoori Derakhshan S.
    J Cell Physiol; 2019 Nov 28; 234(11):19199-19211. PubMed ID: 31026062
    [Abstract] [Full Text] [Related]

  • 30. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker.
    Majed SO, Mustafa SA.
    BMC Cancer; 2021 Apr 29; 21(1):473. PubMed ID: 33910530
    [Abstract] [Full Text] [Related]

  • 31. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 29; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 32. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.
    Breast Cancer Res; 2012 Feb 21; 14(1):R34. PubMed ID: 22353773
    [Abstract] [Full Text] [Related]

  • 33. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
    Tan W, Liang G, Xie X, Jiang W, Tan L, Sanders AJ, Liu Z, Ling Y, Zhong W, Tian Z, Lin W, Gong C.
    Oncologist; 2019 Nov 21; 24(11):e1044-e1054. PubMed ID: 31300482
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.
    Oncol Rep; 2013 Jul 21; 30(1):320-6. PubMed ID: 23673725
    [Abstract] [Full Text] [Related]

  • 37. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.
    Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S.
    PLoS One; 2010 Oct 29; 5(10):e13735. PubMed ID: 21060830
    [Abstract] [Full Text] [Related]

  • 38. Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.
    Peng J, Lin Y, Sheng X, Yuan C, Wang Y, Yin W, Zhou L, Lu J.
    BMC Cancer; 2024 Jul 02; 24(1):789. PubMed ID: 38956544
    [Abstract] [Full Text] [Related]

  • 39. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
    Zhao FL, Dou YC, Wang XF, Han DC, Lv ZG, Ge SL, Zhang YK.
    Mol Biol Rep; 2014 Sep 02; 41(9):5913-22. PubMed ID: 25103018
    [Abstract] [Full Text] [Related]

  • 40. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y, Wang X, Venø MT, Bakholdt V, Sørensen JA, Krogdahl A, Sun Z, Gao S, Kjems J.
    Oncotarget; 2017 Jan 31; 8(5):8206-8214. PubMed ID: 28030794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.